Clinical Trial

Multimorbidity and Sarcopenia Feasibility Study in Chronic Kidney Disease

Study acronym: MaSS-CKD
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 5, 2025 (before its estimated November 2, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this research study is to look at the body composition (such as muscle and fat) in people with chronic kidney disease (CKD) and comparing it with body composition is people without CKD. The investigators currently understand loss of muscle function and mass (sarcopenia) affect the general health of people as they age, but this process seems to be more common, accelerated, and occurs earlier in people with CKD. There is limited evidence in this area, and we believe that if we understand when and how sarcopenia affects people with CKD, investigators can guide future trials and treatments to help treat sarcopenia, and in turn improve quality of life and health outcomes in people with CKD.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-10-25; most recent amendment 2025-08-28.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-08-28
Trial Details
NCT Number NCT06109662
Lead Sponsor University Hospitals of Derby and Burton NHS Foundation Trust
Conditions Chronic Kidney Diseases, Sarcopenia
Enrollment 80 participants
Start Date 2024-02-12
Primary Completion 2025-11-02 (estimated)
Study Completion 2025-11-02 (estimated)
Updated on ClinicalTrials.gov 2025-09-05